US Stock MarketDetailed Quotes
CVS CVS Health
- 58.350
- +0.790+1.37%
Close Aug 16 16:00 ET
- 58.350
- 0.0000.00%
Post 19:54 ET
73.40BMarket Cap10.38P/E (TTM)
58.540High57.300Low7.44MVolume57.360Open57.560Pre Close432.86MTurnover0.59%Turnover Ratio9.02P/E (Static)1.26BShares80.79652wk High0.98P/B73.07BFloat Cap52.18152wk Low2.54Dividend TTM1.25BShs Float102.826Historical High4.35%Div YieldTTM2.15%Amplitude6.424Historical Low58.159Avg Price1Lot Size
CVS Health Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.60%91.23B | 3.70%88.44B | 10.95%357.78B | 11.89%93.81B | 10.60%89.76B | 10.27%88.92B | 11.00%85.28B | 10.39%322.47B | 9.45%83.85B | 9.98%81.16B |
| Operating revenue | 2.60%91.23B | 3.70%88.44B | 10.95%357.78B | 11.89%93.81B | 10.60%89.76B | 10.27%88.92B | 11.00%85.28B | 10.39%322.47B | 9.45%83.85B | 9.98%81.16B |
| Cost of revenue | 3.36%77.85B | 5.53%75.88B | 13.20%303.35B | 14.22%79.94B | 12.43%76.19B | 12.79%75.32B | 13.35%71.9B | 11.66%267.97B | 11.30%69.99B | 10.92%67.77B |
| Gross profit | -1.62%13.38B | -6.09%12.56B | -0.13%54.43B | 0.12%13.88B | 1.37%13.58B | -1.83%13.6B | -0.14%13.38B | 4.57%54.5B | 0.98%13.86B | 5.44%13.39B |
| Operating expense | 4.71%10.34B | 7.41%10.29B | 4.24%39.83B | 4.10%10.5B | 2.75%9.88B | 7.47%9.87B | 2.75%9.58B | 3.22%38.21B | 0.69%10.09B | 4.36%9.61B |
| Other operating expenses | 4.71%10.34B | 7.41%10.29B | 4.24%39.83B | 4.10%10.5B | 2.75%9.88B | 7.47%9.87B | 2.75%9.58B | 3.22%38.21B | 0.69%10.09B | 4.36%9.61B |
| Operating profit | -18.36%3.05B | -40.16%2.27B | -10.38%14.6B | -10.53%3.37B | -2.12%3.7B | -20.11%3.73B | -6.76%3.8B | 7.89%16.29B | 1.78%3.77B | 8.28%3.78B |
| Net non-operating interest income expense | -6.71%-732M | -21.56%-716M | -16.22%-2.66B | -25.00%-690M | -22.44%-693M | -17.67%-686M | -0.51%-589M | 8.63%-2.29B | 9.21%-552M | 5.98%-566M |
| Non-operating interest expense | 6.71%732M | 21.56%716M | 16.22%2.66B | 25.00%690M | 22.44%693M | 17.67%686M | 0.51%589M | -8.63%2.29B | -9.21%552M | -5.98%566M |
| Other net income (expense) | 105.06%24M | 107.65%25M | 90.60%-768M | 132.35%22M | 100.14%11M | -1,202.33%-474M | 32.30%-327M | -296.65%-8.17B | 95.17%-68M | -928.05%-7.66B |
| Special income (charges) | --0 | --0 | 89.73%-856M | --0 | 99.86%-11M | ---496M | 33.52%-349M | -271.98%-8.34B | 92.33%-111M | -869.77%-7.7B |
| -Less：Restructuring and merger&acquisition | --0 | ---- | --507M | --0 | --11M | --496M | ---- | --0 | --0 | --0 |
| -Less:Impairment of capital assets | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,183.85%5.8B | 11.24%99M | 1,338.02%5.22B |
| -Gain on sale of property,plant,equipment | --0 | --0 | 86.22%-349M | --0 | --0 | --0 | -751.22%-349M | ---2.53B | ---12M | ---2.48B |
| Other non- operating income (expenses) | 9.09%24M | 13.64%25M | -47.93%88M | -48.84%22M | -46.34%22M | -48.84%22M | -47.62%22M | -7.14%169M | 13.16%43M | -16.33%41M |
| Income before tax | -9.07%2.34B | -45.12%1.58B | 91.45%11.17B | -14.13%2.71B | 167.93%3.02B | -37.76%2.57B | -4.07%2.88B | -44.61%5.84B | 86.72%3.15B | -307.18%-4.44B |
| Income tax | -13.26%569M | -38.13%456M | 85.88%2.81B | -19.56%658M | 172.15%754M | -39.82%656M | 14.09%737M | -40.78%1.51B | 172.67%818M | -287.28%-1.05B |
| Net income | -7.63%1.77B | -47.53%1.12B | 93.39%8.37B | -12.22%2.05B | 166.64%2.27B | -37.02%1.91B | -9.04%2.14B | -45.84%4.33B | 68.13%2.33B | -314.18%-3.4B |
| Net income continuous Operations | -7.63%1.77B | -47.53%1.12B | 93.39%8.37B | -12.22%2.05B | 166.64%2.27B | -37.02%1.91B | -9.04%2.14B | -45.84%4.33B | 68.13%2.33B | -314.18%-3.4B |
| Minority interest income | -115.38%-2M | 83.33%11M | 50.00%24M | 150.00%1M | -42.86%4M | 30.00%13M | 500.00%6M | 233.33%16M | 80.00%-2M | 163.64%7M |
| Net income attributable to the parent company | -6.89%1.77B | -47.89%1.11B | 93.55%8.34B | -12.34%2.05B | 166.38%2.26B | -37.24%1.9B | -9.26%2.14B | -46.12%4.31B | 67.07%2.33B | -313.14%-3.41B |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -6.89%1.77B | -47.89%1.11B | 93.55%8.34B | -12.34%2.05B | 166.38%2.26B | -37.24%1.9B | -9.26%2.14B | -46.12%4.31B | 67.07%2.33B | -313.14%-3.41B |
| Basic earnings per share | -4.73%1.41 | -46.99%0.88 | 97.26%6.49 | -9.66%1.59 | 167.95%1.76 | -35.93%1.48 | -7.26%1.66 | -45.80%3.29 | 77.78%1.76 | -314.05%-2.59 |
| Diluted earnings per share | -4.73%1.41 | -46.67%0.88 | 98.47%6.47 | -9.71%1.58 | 167.57%1.75 | -35.37%1.48 | -6.78%1.65 | -45.85%3.26 | 78.57%1.75 | -315.83%-2.59 |
| Dividend per share | 9.92%0.665 | 9.92%0.665 | 10.00%2.42 | 10.00%0.605 | 10.00%0.605 | 10.00%0.605 | 10.00%0.605 | 10.00%2.2 | 10.00%0.55 | 10.00%0.55 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
